# Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances

> **NCT02614027** · — · COMPLETED · sponsor: **Asociacion para el Estudio de las Enfermedades Infecciosas** · enrollment: 276 (actual)

## Conditions studied

- Lipodystrophy
- Metabolic Syndrome

## Interventions

- **OTHER:** Evaluation of metabolic syndrome
- **OTHER:** Evaluation of changes in fat by DXA while on current therapy

## Key facts

- **NCT ID:** NCT02614027
- **Lead sponsor:** Asociacion para el Estudio de las Enfermedades Infecciosas
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-02
- **Final completion:** 2018-06
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02614027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02614027, "Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02614027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*